TROG Cancer Research
Members Login   CQMS Login

TROG 05.01 (POST)

Primary Sponsor: Trans Tasman Radiation Oncology Group (TROG)


Post-Operative Concurrent Chemo-Radiotherapy Versus Post-Operative Radiotherapy for Cancer of the Head and Neck (POST)


For patients who have undergone surgery for high-risk skin cancer of the head and neck, this study aims to determine whether there is a difference in time to loco-regional relapse (cancer coming back in the same area) between patients treated with concurrent chemo-radiotherapy (using the chemo drug Carboplatin) versus those participants who were treated with radiotherapy alone.

Final accrual


Trial Status

Closed to follow-up, March 2016

Trial chairperson

Professor Sandro Porceddu,
Princess Alexandra Hospital,

Trial contact

Professor Sandro Porceddu,

Further information

TROG 05.01 on Australian Cancer Trials website

Trial resources for TROG members

TROG 05.01 member page

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.